Mackenzie Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,621
| Closed | -$231K | – | 1453 |
|
|
2021
Q3 | $231K | Buy |
4,621
+1,004
| +28% | +$50.2K | ﹤0.01% | 1247 |
|
|
2021
Q2 | $228K | Buy |
+3,617
| New | +$228K | ﹤0.01% | 1131 |
|
|
2019
Q3 | – | Sell |
-4,820
| Closed | -$233K | – | 1030 |
|
|
2019
Q2 | $233K | Sell |
4,820
-900
| -16% | -$43.5K | ﹤0.01% | 1006 |
|
|
2019
Q1 | $289K | Buy |
+5,720
| New | +$289K | ﹤0.01% | 1112 |
|
|
2018
Q3 | – | Sell |
-119,689
| Closed | -$6.04M | – | 1111 |
|
|
2018
Q2 | $6.04M | Sell |
119,689
-600
| -0.5% | -$30.3K | 0.02% | 410 |
|
|
2018
Q1 | $6.33M | Buy |
+120,289
| New | +$6.33M | 0.02% | 396 |
|
|
2016
Q3 | – | Sell |
-27,342
| Closed | -$769K | – | 709 |
|
|
2016
Q2 | $769K | Buy |
+27,342
| New | +$769K | ﹤0.01% | 665 |
|